Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas - PubMed (original) (raw)
. 1998 Sep;4(9):2195-200.
Affiliations
- PMID: 9748139
Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas
Y Kitadai et al. Clin Cancer Res. 1998 Sep.
Abstract
The purpose of this study was to determine the angiogenic profile of human esophageal carcinomas. The expression of vascular endothelial growth factor (VEGF) was examined in 6 esophageal carcinoma cell lines and 119 human esophageal carcinoma tissues by Northern blot analysis and immunohistochemistry, respectively. Immunohistochemistry using antibodies against CD34 (endothelial cell specific) was carried out on archival specimens, and microvessels were quantitated by counting vessels in a x200 field in the most vascular area of the tumor. All of the cell lines constitutively expressed VEGF mRNA at various levels. A total of 71 of 119 (59.7%) tumors showed intense VEGF immunoreactivity in the cytoplasm of cancer cells. Vessel count was significantly higher in the VEGF-positive tumors than it was in the VEGF-negative tumors. VEGF expression correlated with the depth of tumor invasion, tumor stage, venous invasion, and lymphatic invasion. The survival rate of patients with high vessel density in the tumor was significantly worse than that of patients with low vessel density in the tumor. There was a tendency for poorer prognosis in the group with VEGF-positive tumors compared with that of the group with VEGF-negative tumors. Overall, these results suggest that VEGF is associated with tumor progression by stimulating angiogenesis in human esophageal carcinoma.
Similar articles
- Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H. Kato H, et al. Anticancer Res. 2002 Nov-Dec;22(6C):3977-84. Anticancer Res. 2002. PMID: 12553021 - Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma.
Kitadai Y, Onogawa S, Kuwai T, Matsumura S, Hamada H, Ito M, Tanaka S, Yoshihara M, Chayama K. Kitadai Y, et al. Oncol Rep. 2004 Feb;11(2):315-9. Oncol Rep. 2004. PMID: 14719061 - Vascular endothelial growth factor in esophageal cancer.
Kleespies A, Guba M, Jauch KW, Bruns CJ. Kleespies A, et al. J Surg Oncol. 2004 Aug 1;87(2):95-104. doi: 10.1002/jso.20070. J Surg Oncol. 2004. PMID: 15282704 Review. - Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma.
Lionello M, Staffieri A, Marioni G. Lionello M, et al. Acta Otolaryngol. 2012 Jun;132(6):574-82. doi: 10.3109/00016489.2011.652308. Epub 2012 Apr 12. Acta Otolaryngol. 2012. PMID: 22497582 Review.
Cited by
- Chondromodulin-1 and vascular endothelial growth factor-A expression in esophageal squamous cell carcinoma: accelerator and brake theory for angiogenesis at the early stage of cancer progression.
Kumagai Y, Tachikawa T, Higashi M, Sobajima J, Takahashi A, Amano K, Ishibashi KI, Mochiki E, Yakabi K, Tamaru JI, Ishida H. Kumagai Y, et al. Esophagus. 2020 Apr;17(2):159-167. doi: 10.1007/s10388-019-00695-8. Epub 2019 Oct 8. Esophagus. 2020. PMID: 31595395 - Microvessel density as a prognostic factor in esophageal squamous cell cancer patients: A meta-analysis.
Ma G, Zhang J, Jiang H, Zhang N, Zhu Y, Deng Y, Zhou Q. Ma G, et al. Medicine (Baltimore). 2017 Jul;96(29):e7600. doi: 10.1097/MD.0000000000007600. Medicine (Baltimore). 2017. PMID: 28723804 Free PMC article. Review. - Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects.
Kubota T, Fujiwara H, Amaike H, Takashima K, Inada S, Atsuji K, Yoshimura M, Matsumoto K, Nakamura T, Yamagishi H. Kubota T, et al. Cancer Sci. 2004 Apr;95(4):321-7. doi: 10.1111/j.1349-7006.2004.tb03210.x. Cancer Sci. 2004. PMID: 15072590 Free PMC article. - Gastric cancer and the epoch of immunotherapy approaches.
Niccolai E, Taddei A, Prisco D, Amedei A. Niccolai E, et al. World J Gastroenterol. 2015 May 21;21(19):5778-93. doi: 10.3748/wjg.v21.i19.5778. World J Gastroenterol. 2015. PMID: 26019442 Free PMC article. Review. - Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?
Zampeli E, Karamanolis G, Morfopoulos G, Xirouchakis E, Kalampoki V, Michopoulos S, Savva S, Tzias V, Zouboulis-Vafiadis I, Kamberoglou D, Ladas SD. Zampeli E, et al. Dig Dis Sci. 2012 May;57(5):1190-6. doi: 10.1007/s10620-011-1990-6. Epub 2011 Dec 7. Dig Dis Sci. 2012. PMID: 22147251
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical